3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
8
Prostatic Neoplasms
6
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Osteoporosis
3
Polycystic Ovary Syndrome
2
Obesity
2
Neoplasm Metastasis
2
Lymphoma
2
Leukemia
2
Bone Diseases, Metabolic
2
Vitamin D Deficiency
1
Sexual Dysfunction, Physiological
1
Psoriasis
1
Pain
1
Osteoarthritis
1
Neoplasms
1
Multiple Myeloma
1
Melanoma, Cutaneous Malignant
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Lung Neoplasms
1
Leukemia, Myeloid, Acute
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Insulin Resistance
1
Inflammation
1
Hypertension
1
Giant Cell Tumor of Bone
1
Gastrointestinal Neoplasms
1
Interventions
Vitamin D
1
Plasma Exchange
1
Immunoglobulins, Intravenous
1
Fish Oils
1
Fatty Acids, Omega-3
1
Eicosapentaenoic Acid
1
Docosahexaenoic Acids
1
Cholecalciferol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Autoimmune Diseases
×
Vitamin D
×
Clear all
NCT01351805
2025-12-03
VITAL
Brigham and Women's Hospital
Phase NA
Completed
25,871 enrolled
15 charts